These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 24689098)

  • 1. Characterization of focal liver lesions using contrast enhanced ultrasound as a first line method: a large monocentric experience.
    Sporea I; Martie A; Bota S; Sirli R; Popescu A; Dănila M
    J Gastrointestin Liver Dis; 2014 Mar; 23(1):57-63. PubMed ID: 24689098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Undetermined focal liver lesions on gray-scale ultrasound in patients with fatty liver: characterization with contrast-enhanced ultrasound.
    Wang ZL; Tang J; Weskott HP; Li JL; Wang W; Luo YK; An LC; Xu JH
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1511-9. PubMed ID: 18713302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How useful is contrast enhanced ultrasonography for the characterization of focal liver lesions?
    Sporea I; Sirli R; Martie A; Popescu A; Danila M
    J Gastrointestin Liver Dis; 2010 Dec; 19(4):393-8. PubMed ID: 21188330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver tumor characterization--comments and illustrations regarding guidelines.
    Dietrich CF
    Ultraschall Med; 2012 Jul; 33 Suppl 1():S22-30. PubMed ID: 22723025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver tumor characterization--review of the literature.
    Dietrich CF; Maddalena ME; Cui XW; Schreiber-Dietrich D; Ignee A
    Ultraschall Med; 2012 Jul; 33 Suppl 1():S3-10. PubMed ID: 22723026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The contribution of contrast enhanced ultrasound for the characterization of benign liver lesions in clinical practice - a monocentric experience.
    Martie A; Bota S; Sporea I; Sirli R; Popescu A; Danila M
    Med Ultrason; 2012 Dec; 14(4):283-7. PubMed ID: 23243641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast-enhanced ultrasound (CEUS) has excellent diagnostic accuracy in differentiating focal liver lesions: results from a Swiss tertiary gastroenterological centre.
    Sawatzki M; Meyenberger C; Brand S; Semela D
    Swiss Med Wkly; 2019 Jun; 149():w20087. PubMed ID: 31256416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast enhanced ultrasound in focal liver lesions--a cost efficiency study.
    Sirli R; Sporea I; Martie A; Popescu A; Dănilă M
    Med Ultrason; 2010 Dec; 12(4):280-5. PubMed ID: 21210012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of 2D- Shear Wave Elastography for Characterisation of Focal Liver Lesions.
    Gerber L; Fitting D; Srikantharajah K; Weiler N; Kyriakidou G; Bojunga J; Schulze F; Bon D; Zeuzem S; Friedrich-Rust M
    J Gastrointestin Liver Dis; 2017 Sep; 26(3):283-290. PubMed ID: 28922441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast-enhanced ultrasound (CEUS) in the diagnostic algorithm of hepatocellular and cholangiocellular carcinoma, comments on the AASLD guidelines.
    Dietrich CF; Cui XW; Boozari B; Hocke M; Ignee A
    Ultraschall Med; 2012 Jul; 33 Suppl 1():S57-66. PubMed ID: 22723030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-enhanced ultrasound (CEUS) for the evaluation of focal liver lesions - a prospective multicenter study of its usefulness in clinical practice.
    Sporea I; Badea R; Popescu A; Spârchez Z; Sirli RL; Dănilă M; Săndulescu L; Bota S; Calescu DP; Nedelcu D; Brisc C; Ciobâca L; Gheorghe L; Socaciu M; Martie A; Ioaniţescu S; Tamas A; Streba CT; Iordache M; Simionov I; Jinga M; Anghel A; Cijevschi Prelipcean C; Mihai C; Stanciu SM; Stoicescu D; Dumitru E; Pietrareanu C; Bartos D; Manzat Saplacan R; Pârvulescu I; Vădan R; Smira G; Tuţă L; Săftoiu A
    Ultraschall Med; 2014 Jun; 35(3):259-66. PubMed ID: 24563420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic accuracy of CEUS in the differential diagnosis of small (≤ 20  mm) and subcentimetric (≤ 10  mm) focal liver lesions in comparison with histology. Results of the DEGUM multicenter trial.
    Strobel D; Bernatik T; Blank W; Schuler A; Greis C; Dietrich CF; Seitz K
    Ultraschall Med; 2011 Dec; 32(6):593-7. PubMed ID: 22161556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast enhanced ultrasound for the characterization of hepatocellular carcinoma.
    Martie A; Sporea I; Popescu A; Sirli R; Dănilă M; Serban C; Ardelean M; Bota S; Sendroiu M; Chisevescu D
    Med Ultrason; 2011 Jun; 13(2):108-13. PubMed ID: 21655536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast enhanced ultrasound for the diagnosis of liver hemangiomas in clinical practice.
    Sirli R; Sporea I; Popescu A; Dănilă M; Martie A; Bota S; Jurchis A; Sendroiu M
    Med Ultrason; 2011 Jun; 13(2):95-101. PubMed ID: 21655534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast Enhanced Ultrasound for the evaluation of focal liver lesions in daily practice. A multicentre study.
    Sporea I; Badea R; Martie A; Dumitru E; Ioaniţescu S; Şirli R; Socaciu M; Popescu A; Dănilă M; Voiculescu M
    Med Ultrason; 2012 Jun; 14(2):95-100. PubMed ID: 22675708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast enhanced ultrasound for the characterization of focal liver lesions.
    Sporea I; Badea R; Martie A; Sirli R; Socaciu M; Popescu A; Dănilă M
    Med Ultrason; 2011 Mar; 13(1):38-44. PubMed ID: 21390342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS).
    Strobel D; Seitz K; Blank W; Schuler A; Dietrich CF; von Herbay A; Friedrich-Rust M; Bernatik T
    Ultraschall Med; 2009 Aug; 30(4):376-82. PubMed ID: 19688669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast-Enhanced Ultrasound for the Characterization of Malignant versus Benign Focal Liver Lesions in a Prospective Multicenter Experience - The SRUMB Study.
    Sporea I; Săndulescu DL; Şirli R; Popescu A; Danilă M; Spârchez Z; Mihai C; Ioanițescu S; Moga T; Timar B; Brisc C; Nedelcu D; Săftoiu A; Enăchescu V; Badea R
    J Gastrointestin Liver Dis; 2019 Jun; 28():191-196. PubMed ID: 31204417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of wash-in and wash-out time in the diagnosis between hepatocellular carcinoma and other hepatic nodules with similar vascular pattern on contrast-enhanced ultrasound.
    Kong WT; Wang WP; Huang BJ; Ding H; Mao F
    J Gastroenterol Hepatol; 2014 Mar; 29(3):576-80. PubMed ID: 24118042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of intrahepatic cholangiocarcinoma from hepatocellular carcinoma in high-risk patients: A predictive model using contrast-enhanced ultrasound.
    Chen LD; Ruan SM; Liang JY; Yang Z; Shen SL; Huang Y; Li W; Wang Z; Xie XY; Lu MD; Kuang M; Wang W
    World J Gastroenterol; 2018 Sep; 24(33):3786-3798. PubMed ID: 30197484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.